Market capitalization | $37.26b |
Enterprise Value | $37.39b |
P/E (TTM) P/E ratio | 13.44 |
EV/FCF (TTM) EV/FCF | 16.54 |
EV/Sales (TTM) EV/Sales | 0.24 |
P/S ratio (TTM) P/S ratio | 0.24 |
P/B ratio (TTM) P/B ratio | 1.36 |
Revenue growth (TTM) Revenue growth | 6.64% |
Revenue (TTM) Revenue | $157.75b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
21 Analysts have issued a Centene forecast:
21 Analysts have issued a Centene forecast:
Jun '24 |
+/-
%
|
||
Revenue | 157,745 157,745 |
7%
7%
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 3,573 3,573 |
1%
1%
|
Net Profit | 2,823 2,823 |
4%
4%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.
Head office | United States |
CEO | Sarah London |
Employees | 76,000 |
Founded | 1984 |
Website | www.centene.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.